Mayport LLC Sells 25 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Mayport LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 884 shares of the healthcare conglomerate’s stock after selling 25 shares during the quarter. Mayport LLC’s holdings in UnitedHealth Group were worth $517,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $27,000. Macroview Investment Management LLC lifted its stake in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares during the last quarter. Delos Wealth Advisors LLC grew its stake in shares of UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter worth approximately $31,000. Finally, Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.7 %

Shares of UnitedHealth Group stock opened at $561.50 on Thursday. The firm’s 50 day moving average price is $584.21 and its 200-day moving average price is $532.84. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63. The company has a market cap of $518.50 billion, a P/E ratio of 37.88, a PEG ratio of 1.69 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.56 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.50%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 55.70%.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday. Truist Financial reaffirmed a “buy” rating and set a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price objective for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Morgan Stanley dropped their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday. Finally, HSBC upped their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. One analyst has rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $615.16.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.